---
category: news
title: "Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2022"
excerpt: "PGS builds upon the foundation of Digital Laparoscopy by adding machine vision, augmented intelligence, and deep learning capabilities ... and $0.3 million in services. For the three months ended March 31, 2022, total operating expenses were $18.2 million ..."
publishedDateTime: 2022-05-04T20:05:00Z
originalUrl: "https://finance.dailyherald.com/dailyherald/article/bizwire-2022-5-4-asensus-surgical-inc-reports-operating-and-financial-results-for-the-first-quarter-2022"
webUrl: "https://finance.dailyherald.com/dailyherald/article/bizwire-2022-5-4-asensus-surgical-inc-reports-operating-and-financial-results-for-the-first-quarter-2022"
type: article
quality: 0
heat: -1
published: false

provider:
  name: Daily Herald
  domain: dailyherald.com

topics:
  - AI in Finance
  - AI

related:
  - title: "Perimeter Medical Imaging AI Reports 2021 Financial Results and Provides Corporate Update"
    excerpt: "Perimeter officially progresses to commercial stage with its first S-Series OCT installation. Clinical development of B-Series OCT with ImgAssist AI advances into late-stage validation activities with the initiation of a multi-center, randomized ..."
    publishedDateTime: 2022-05-02T21:21:00Z
    webUrl: "https://www.benzinga.com/pressreleases/22/05/b26949844/perimeter-medical-imaging-ai-reports-2021-financial-results-and-provides-corporate-update"
    ampWebUrl: "https://www.benzinga.com/amp/content/26949844"
    cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/26949844"
    type: article
    provider:
      name: Benzinga.com
      domain: benzinga.com
    quality: 48
    images:
      - url: "https://www.benzinga.com/next-assets/images/schema-image-default.png"
        width: 1043
        height: 1043
        isCached: true
  - title: "Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights"
    excerpt: "DALLAS, May 3, 2022 /PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR Â® artificial intelligence (\"A.I ... the potential of combination therapy for these two agents."
    publishedDateTime: 2022-05-03T23:30:00Z
    webUrl: "https://www.kron4.com/business/press-releases/cision/20220503DA44966/lantern-pharma-reports-first-quarter-2022-financial-results-and-operational-highlights/"
    type: article
    provider:
      name: KRON4
      domain: kron4.com
    quality: 0

secured: "HrPo8QTb6jSF8/5B4RqHAi226v/xhKuUCG8BJH6eDNUZTjHjdprC3Ntz25zrZRol2Yzb/EFVI2hEhWFDuWGYqFI/3tJ8RG+LBr123SZNz5pM/OrGSY0AfTUkEmzPXwtIqIjqsJW211KunVfZP3dYVwpn/ADtEEAVmlyeKX/75yutPbN/fggdx2v9o/Q/BMEP597m7GkYjNqFF1utZF9H8ASV84z54AAlpzMeqCL3UrXZapSubE9UNtu38Nr0SOdCO2Onmp9MXPOaUXUYKNDYw14h583OyHuffGSUKvnZJM7mvsl3eQjcxS5ZsBv7S2VAaGo/JDtIxREvjlEsIIboKPh0rjUEoA4CZJjZOtmFY1U=;aU9poiazfL9FVSEKdA62qw=="
---

